In skeletal muscle, IL-6 has been shown to induce insulin resistance (euglycemic–hyperinsulinemic clamps) possibly by an increase in intramuscular NEFA uptake, accumulation of NEFA-derived metabolites, and inhibition of glucose disposal (228). The gene discussed is IL6; the disease is Insulin resistance.